Evidence-Based Complementary and Alternative Medicine

Recently Published Articles

Medication Rules in Herbal Medicine for Mild Cognitive Impairment: A Network Pharmacology and Data Mining Study, Z. Chang, Yu-Chun Wang, Danfeng Tian, Wen-Yue Hu, Zhen-Yi Wang, Gan-Lu Liu, Hua-Ping Ma, Yu-Li Hu, Bin Wu, and Zhen-Yun Han Volume 2022 (2022), Article ID 2478940, 15 pages

Ta-Xi-San Suppresses Atopic Dermatitis Involved in Multitarget Mechanism Using Experimental and Network Pharmacology Analysis, Wenbing Zhi, Chun Li, Hong Zhang, Yiding Zhao, Shiyu Zong, Qiqi Liu, Jie Zhou, Chunliu Wang, Tingting Sun, Yang Liu, and Ye Li Volume 2022 (2022), Article ID 8441938, 15 pages

Analysis of Relevant Factors Affecting the Pregnancy Rate of Frozen-Thawed Embryo Transfer Cycle, Ning Liu, Yuhong Wang, Jing Lu, Xihui Zhang, Yunjing Zhang, Haijun Zhao, Yijiao Zhang, and Wenliang Chang Volume 2022 (2022), Article ID 2842278, 5 pages

Bisphosphates for Osteoporosis: A Bibliometric Analysis of the Most Cited Articles, Yu Zhang, Man Hu, Lei Zhu, Junwu Wang, Pingchuan Wang, Pengzhi Shi, Wenjie Zhao, Xin Liu, Qing Peng, Bo Meng, Chen Chen, Xinmin Feng, Yongxiang Wang, and Liang Zhang Volume 2022 (2022), Article ID 4565069, 14 pages

Microorganism Determination of 10 Proprietary Chinese Medicines for Children by Plate Culture or Membrane Filtration, Hong Cai, Danchun Jia, and Yuan Ke Volume 2022 (2022), Article ID 6382676, 5 pages

Resveratrol Ameliorates Lipopolysaccharide-Induced Sudden Sensorineural Hearing Loss in In Vitro Model through Multitarget Antiapoptotic Mechanism Based on Network Pharmacology and Molecular Docking, Shiming Ye, Jing Liu, Qi Dong, Xinxin Wang, and Wandong She Volume 2022 (2022), Article ID 6404588, 11 pages

Corrigendum to "The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways", Shufang Liang, Yong Zou, Jingdong Gao, Xiaolin Liu, Wanfu Lin, Zifei Yin, Juan Du, Ya'ni Zhang, Qunwei Chen, Shu Li, Binbin Cheng, and Changquan Ling Volume 2022 (2022), Article ID 9780826, 3 pages

Chromobox Homologue 7 Acts as a Tumor Suppressor in Both Lung Adenocarcinoma and Lung Squamous Cell Carcinoma via Inhibiting ERK/MAPK Signaling Pathway, Jinlong Huang, Weiqing Zhang, Dongliang Lin, Luoyu Lian, Wenshan Hong, and Zhendong Xu Volume 2022 (2022), Article ID 4952185, 10 pages

Analysis of Risk Factors and Nursing Strategies for Postoperative Hemorrhage of Benign Prostatic Hyperplasia, Shanshan Jin, Zhaoyue Liu, Yan Liu, Jingzhang Wu, and Qian Yu Volume 2022 (2022), Article ID 4205015, 5 pages

Naringin Regulates Microglia BV-2 Activation and Inflammation via the JAK/STAT3 Pathway, Li Li, Ru Liu, Jing He, Jing Li, Juan Guo, Yun Chen, and Ke Ji Volume 2022 (2022), Article ID 3492058, 10 pages

The Effect of Yiqi Huoxue Tongluo Decoction on Spinal Cord Microglia Activation and ASK1-MKK3-p38 Signal Pathway in Rats with Diabetic Neuropathic Pain, Fanjing Wang, Heyong Tang, Junlong Ma, Lianzhi Cheng, Yixuan Lin, Jindong Zhao, Guoming Shen, Zhaohui Fang, and Aijuan Jiang Volume 2022 (2022), Article ID 2408265, 11 pages

Molecular Mechanism of the Effect of Zhizhu Pill on Gastroesophageal Reflux Disease Based on Network Pharmacology and Molecular Docking, Jinke Huang, Yitian Wang, Peng Xu, Jiali Liu, Jinxin Ma, Yu Wang, Zhihong Liu, Mi Lv, Fengyun Wang, and Xudong Tang Volume 2022 (2022), Article ID 2996865, 13 pages

Impact of Kangaroo Mother Care Intervention on Immunological and Pulmonary Functions of Preterm Infants during Breastfeeding, Juan Yang, Yanan Guo, and Yuying Dai Volume 2022 (2022), Article ID 3180871, 7 pages

Best regards, The Evidence-Based Complementary and Alternative Medicine team ecam@hindawi.com Hindawi Limited Hindawi.com | Twitter | Facebook | LinkedIn | YouTube

Hindawi Limited, Adam House, Third Floor 1 Fitzroy Square, London W1T 5HF, UK www.hindawi.com

You have received this email to evidencehub.evidencehub@blogger.com from Evidence-Based Complementary and Alternative Medicine (published by Hindawi Limited, company number: 08671628, with registered address: Adam House, Third Floor, 1 Fitzroy Square, London, W1T 5HF, UK) because you have actively signed up to receive content alerts from Evidence-Based Complementary and Alternative Medicine. Hindawi respects your right to privacy and will not disclose your email address to any third parties without your consent. To see the types of information we may hold or collect about you and how we may use that information, please see our Privacy Policy. If you would prefer not to receive any further messages from Evidence-Based Complementary and Alternative Medicine or Hindawi, please contact Privacy@hindawi.com or click here to unsubscribe from the alert mailing list.